1. Stocks
    2. /
  2. Johnson & Johnson (NYSE: JNJ)
    3. /

Johnson & Johnson (NYSE: JNJ) Share Price and News

$253.79 $-1.77 (-0.7%) 20 October 2026 at 7:00:00 am AEDT

Johnson & Johnson Chart and Price Data

About Johnson & Johnson

Last updated 20-10-2026, 07:00:00am AEDT
Current Price $253.79
Change $-1.77 (-0.7%)
Close Price $253.79
Open Price $254.43
Bid $252.85
Ask $254.00
Day Range $251.50 - $255.56
Year Range $184.66 - $281.07
Volume 8,847,935
Average Volume 7,083,008
Market Cap $615,874,044,000.00
Earnings Per Share $6.59

    • Johnson & Johnson (NYSE: JNJ)
    Latest News

    Investor happily looking at rising share price on laptop.
    Investing Strategies

    5 international value shares with a positive outlook: analyst

    | Bernd Struben

    Aussie investors looking to diversify their share portfolios could consider investing some of their funds overseas.

    Read more »

    US 100 dollar notes with a gavel on top of it
    International Stock News

    Supreme Court rules Johnson & Johnson must pay $2.1 billion in baby powder lawsuit

    | Eric Volkman

    The company has set aside nearly $4 billion as a "litigation expense."

    Read more »

    Platinum Asset Management's Dr Bianca Ogden
    Ask a Fund Manager

    This fundie has a PhD in healthcare: now she invests in it

    | Tony Yoo

    Ask A Fund Manager: Platinum Asset Management's Dr Bianca Ogden tells how she used to work for the company that's…

    Read more »

    Covid-19 vaccine
    International Stock News

    How Johnson & Johnson beat expectations in Q1

    | Keith Speights

    The healthcare giant saw a marked recovery from the negative impacts of the COVID-19 pandemic.

    Read more »

    A line of people sitting at a long desk in an annual general meeting
    International Stock News

    2 things investors need to look for in Johnson & Johnson's earnings tomorrow

    | Alex Carchidi

    Formally addressing the recent challenges will help to put shareholders at ease again.

    Read more »

    health worker holding a vaccine in their hand
    International Stock News

    The Johnson & Johnson COVID vaccine halt: here's what investors need to know

    | Adria Cimino

    Officials are investigating "severe" blood clots in some people.

    Read more »

    health worker wearing personal protective equipment and gesturing stop with her hands
    International Stock News

    U.S. gives Johnson & Johnson's COVID-19 vaccine a timeout

    | Cory Renauer

    Out of an abundance of caution, the FDA and CDC have recommended a pause in the use of the only…

    Read more »

    Five different piggy banks, indicating a diverse share portfolio.
    Exchange-Traded Funds (ETFs)

    2 top ASX ETFs to buy right now

    | Sebastian Bowen

    The iShares S&P 500 ETF (ASX: IVV) is one of two ASX ETFs to buy today for ASX share portfolio…

    Read more »

    coronavirus vaccine represented by gloved hand drawing down from syringe
    International Stock News

    Johnson & Johnson coronavirus vaccine wins FDA authorisation

    | Eric Volkman

    The big pharmaceutical company's jab has some important advantages.

    Read more »

    Cash piled up in the middle of a bear trap symbolising risky investments
    International Stock News

    Why Moderna Is Less Risky Than You Think

    | Manali Bhade

    Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

    Read more »

    doctor giving little boy vaccine injection in his arm
    International Stock News

    Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial

    | Brian Orelli, PhD

    The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.

    Read more »

    doctor making thumbs up gesture and holding vial labelled 'covid-19 vaccine' representing covid shares
    International Stock News

    The surefire vaccine winner following AstraZeneca's COVID-19 trial pause

    | Keith Speights

    Hint: It's not Moderna.

    Read more »

    Profile

    since

    Note